1. What's the Granules India Ltd share price today? Granules India Ltd share price was Rs 486.85 at close on 20th Jun 2025. Granules India Ltd share price was up by 1.58% over the previous closing ...

Granules India Share Price – Track LIVE BSE/NSE stock prices of Granules India with insights on performance, fundamentals, market cap, shareholding, financials, company profile, balance sheet, annual ...

Shares of Granules India will be in focus on Monday after the company announced that its active pharmaceutical ingredient (API) facility in Telangana has received an observation from the US Food and ...

In FY 2014-15, Granules India crossed Rs 1200 crore in revenue.With a view to broad base the investor base by encouraging the participation of the small investors and also to increase the ...

Granules India Q4 News Q4 results today: IRCTC, Deepak Nitrate, SAIL, Cummins, Bata India, Nuvama Wealth, 3M, Natco Pharma, Finolex on May 28 2 min read 28 May 2025 ...

ABFRL, Adani Total Gas, CESC, Granules India, IRB Infra, Jindal Stainless, Poonawalla Fincorp, and SJVN are the eight stocks that will be removed, Moneycontrol News. June 24, 2025 / 08:12 IST .

Granules India is trading 0.81% upper at Rs 484.30 as compared to its last closing price. Granules India has been trading in the price range of 490.50 & 478.80. Granules India has given-18.91% in ...

The Spectracide 53944 is a highly grated granular insecticide for aphid control. Aphids are insects that feed on the sap of plants. These granules contain the active ingredient Gamma-Cyhalothrin 0.08% ...

Granules' revenue increased by 1.8% from the same quarter last year to ₹1,197.5 crore. The company had reported a topline of ₹1,175 crore in the base quarter. Its Earnings Before Interest, Tax, ...

Granules India Share Price | The share touched a 52-week high of Rs 724.55 and a 52-week low of Rs 412.05 on 02 September, 2024 and 07 April, 2025, respectively.

Hyderabad: Granules India has announced that the Company's Bonthapally API Unit-I facility has concluded a U.S. Food and Drugs Administration (US FDA) inspection with one 483 observation. The facility ...

Granules India's Bonthapally facility receives observation from U.S. FDA for API manufacturing, including paracetamol, Metformin, and Guaifenesin.